Workflow
农林牧渔周观点:猪价承压小幅走弱,关注宠物食品线上销售增长-20250817
Shenwan Hongyuan Securities·2025-08-17 13:15

Investment Rating - The industry investment rating is "Overweight" indicating that the industry is expected to outperform the overall market [2][4][49]. Core Insights - The report highlights the pressure on pig prices, which have slightly weakened, and emphasizes the growth in online sales of pet food [1][4]. - The report suggests focusing on the "anti-involution" process in the pig farming industry and capturing investment opportunities in quality pig enterprises [4][5]. - Short-term price weakness combined with policy guidance may lead to a restart in capacity reduction, with a recommendation to closely monitor the implementation of industry regulation measures [4][5]. Summary by Sections Agricultural Stock Market Performance - The Shenwan Agricultural, Forestry, Animal Husbandry, and Fishery Index fell by 0.1%, while the CSI 300 rose by 2.4% [4][5]. - Top five gainers included COFCO Sugar (35.9%), Shenlian Bio (14.0%), and Xiaoming Co. (8.9%) [4][5]. Pig Farming - The average price of external three yuan pigs was 13.67 yuan/kg, down 0.5% week-on-week [4][5]. - The average weight of market pigs was stable at 127.82 kg, with a slight increase of 0.02 kg per head week-on-week [4][5]. - The average price of weaned piglets was 429 yuan/head, down 11 yuan week-on-week [4][5]. Poultry Farming - The average selling price of white feather broiler chicks was 3.48 yuan/chick, up 18.4% week-on-week [4][5]. - The average selling price of white feather broiler meat was 3.35 yuan/kg, up 2.6% week-on-week [4][5]. Pet Food - In July, the total sales on platforms like Tmall, JD, and Douyin reached approximately 2 billion yuan, a year-on-year increase of 5% [4][5]. - The cumulative sales from January to July were 16.9 billion yuan, up 12% year-on-year [4][5]. Animal Health - The report indicates a recovery in the performance of animal health companies due to stable profits in pig farming and increased demand for vaccines [4][5]. - Jinhe Bio reported a revenue of 1.39 billion yuan in the first half of 2025, a year-on-year increase of 30.5% [4][5].